Skip to main content
Quest Diagnostics

Thyroid

Thyroid cancer tests that helps to determine the right treatment

Quest Diagnostics, the world’s leading provider of diagnostic testing, information, and services, offers a new molecular test panel designed to help physicians determine if a thyroid gland is cancerous and requires surgical removal. The test is believed to be the most comprehensive panel clinically available to identify mutations associated with 4 gene markers indicated by the American Thyroid Association’s guidelines for clinical management of indeterminate thyroid biopsies.

Solid Tumor Core Panel

Quest also offers a 49-gene Solid Tumor Core Panel to help physicians choose the most appropriate therapy for their patients based on the alterations found in the individual’s tumor sample DNA.

Thyroid Cancer Mutation Panel
Solid Tumor Core Panel
This information is provided for informational purposes only and is not intended as medical advice. A physician’s test selection and interpretation, diagnosis, and patient management decisions should be based on his/her education, clinical expertise, and assessment of the patient.

During the COVID-19 health crisis, fast action and trusted information matter more than ever.

Find out what's happening

Learn More

Cancer

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.